TRIDOPA levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

tridopa levodopa/carbidopa/entacapone 125/31.25/200 mg tablet bottle

stada pharmaceuticals australia pty ltd - carbidopa monohydrate, quantity: 33.75 mg (equivalent: carbidopa, qty 31.25 mg); entacapone, quantity: 200 mg; levodopa, quantity: 125 mg - tablet, film coated - excipient ingredients: magnesium stearate; powdered cellulose; sodium sulfate; hyprolose; microcrystalline cellulose; trehalose dihydrate; carmellose sodium; titanium dioxide; iron oxide yellow; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.

Penicillamine 125mg tablets Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

penicillamine 125mg tablets

alliance healthcare (distribution) ltd - penicillamine - oral tablet - 125mg

D-PENAMINE penicillamine 125 mg tablet bottle Austrália - inglês - Department of Health (Therapeutic Goods Administration)

d-penamine penicillamine 125 mg tablet bottle

alphapharm pty ltd - penicillamine, quantity: 125 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; glycerol; titanium dioxide; hypromellose; stearic acid; sodium starch glycollate - severe, active rheumatoid arthritis. as a chelating agent in the treatment of wilson's disease and lead poisoning. d-penamine will enhance urinary excretion of gold and mercury and other heavy metals. in the treatment of cysturia in cases where high-fluid regimens are not adequate, or in conjunction with them.

Vancomycin 125mg capsules Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

vancomycin 125mg capsules

morningside healthcare ltd - vancomycin hydrochloride - oral capsule - 125mg